Michael Benatar Selected Research

Michael Benatar Research Topics

Disease

34	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023 - 04/2007
27	Myasthenia Gravis 01/2024 - 07/2006
8	Disease Progression 01/2023 - 05/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2013
3	Infections 12/2023 - 05/2010
3	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2012
3	Asymptomatic Diseases 01/2022 - 01/2018
2	Neoplasms (Cancer) 12/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 04/2015
2	Spinal Cord Diseases 01/2023 - 02/2007
2	Stroke (Strokes) 01/2023 - 02/2009
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 02/2015
2	Headache (Headaches) 01/2021 - 12/2017
2	Thymoma (Thymic Carcinoma) 11/2020 - 12/2017
2	Proteostasis Deficiencies 05/2013 - 03/2013
2	Ischemic Stroke 02/2009 - 01/2008
1	Prodromal Symptoms 01/2023
1	Spastic Ataxia 01/2023
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Meningococcal Infections 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Fatigue 01/2018
1	Thymus Neoplasms (Thymus Neoplasm) 12/2017
1	Meningococcal Meningitis 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Respiratory Insufficiency (Respiratory Failure) 12/2016
1	Guillain-Barre Syndrome 12/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2016
1	Vascular Diseases (Vascular Disease) 07/2015

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2010
12	Cholinergic ReceptorsIBA 12/2023 - 07/2006
8	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2012
5	AntibodiesIBA 12/2023 - 07/2006
4	glucose-mannose-glucoseIBA 01/2024 - 01/2019
4	Rituximab (Mabthera)FDA Link 12/2021 - 09/2017
4	Prednisone (Sone)FDA LinkGeneric 11/2020 - 03/2016
3	Monoclonal AntibodiesIBA 01/2024 - 01/2021
3	neonatal Fc receptorIBA 12/2023 - 01/2021
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2020 - 01/2018
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 06/2007
3	Edrophonium (Tensilon)FDA LinkGeneric 01/2019 - 07/2006
3	Intravenous Immunoglobulins (IVIG)FDA Link 12/2017 - 10/2013
3	SteroidsIBA 07/2016 - 10/2008
3	Valosin Containing ProteinIBA 09/2012 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	AutoantibodiesIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2015
2	Complement System Proteins (Complement)IBA 01/2023 - 12/2017
2	Superoxide Dismutase-1IBA 01/2022 - 03/2013
2	tofersenIBA 01/2022 - 01/2022
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2022 - 03/2017
2	Antisense OligonucleotidesIBA 01/2022 - 01/2019
2	margatoxinIBA 11/2020 - 01/2019
2	Complement Inactivating AgentsIBA 01/2020 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2012
2	Phosphotransferases (Kinase)IBA 01/2019 - 09/2017
2	eculizumab FDA Link 01/2019 - 12/2017
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 03/2016 - 02/2008
2	Amino Acids FDA Link 03/2013 - 12/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2010 - 02/2008
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	N 30IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Nitrous Oxide (Laughing Gas)IBA 01/2023
1	B-Cell Maturation AntigenIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	NeopterinIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	EdaravoneIBA 08/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	DipeptidesIBA 01/2021
1	rozanolixizumabIBA 01/2021
1	ChitinasesIBA 01/2020
1	zilucoplanIBA 01/2020
1	rho-Associated KinasesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	fasudil (AT 877)IBA 01/2019
1	polyetheretherketoneIBA 01/2018
1	arimoclomolIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 09/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2016
1	Retinaldehyde (Retinal)IBA 07/2015
1	Immunomodulating AgentsIBA 04/2015

Therapy/Procedure

24	Therapeutics 01/2024 - 04/2007
6	Thymectomy 11/2020 - 10/2013
5	Activities of Daily Living (ADL) 01/2024 - 07/2016
2	Plasma Exchange 12/2017 - 10/2013
1	Traditional Medicine (Folk Remedies) 12/2023
1	Injections 12/2023
1	Plasmapheresis 12/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2016
1	Artificial Respiration (Mechanical Ventilation) 12/2016
1	Immunotherapy 12/2016
1	Noninvasive Ventilation 12/2016
1	Denervation 02/2015